Taiwan practical consensus for evaluation and management of small bowel bleeding

Small bowel bleeding, accounting for 5-10% of gastrointestinal bleeding episodes, presents a distinct diagnostic challenge due to the organ's length and anatomical complexity. Over recent years, the management of small bowel bleeding has significantly evolved, driven by advancements in both diagnostic and therapeutic technologies. This Taiwan association for the study of intestinal diseases (TASID) practical consensus integrates local epidemiology, up-to-date diagnostic advances including early small bowel capsule endoscopy, and emerging treatments for vascular lesions like angiodysplasia. This practical consensus is divided into four major parts, including: I. terminology regarding small bowel bleeding and differential diagnosis II, evaluation of suspected small bowel bleeding III. endoscopy for small bowel bleeding and IV. medical treatment. Clinicians should be equipped to identify common causes of small bowel bleeding, understand the advantages and limitations of various evaluation methods, and apply a stepwise, evidence-based approach in managing these patients.